CONMED Corporation
CNMD
$38.46
-$0.95-2.41%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 10.44% | -1.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.44% | -1.29% | |||
| Cost of Revenue | 32.62% | -0.35% | |||
| Gross Profit | -6.93% | -2.02% | |||
| SG&A Expenses | -3.30% | 0.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.88% | 0.14% | |||
| Operating Income | -26.08% | -11.68% | |||
| Income Before Tax | 584.60% | -85.72% | |||
| Income Tax Expenses | 785.01% | -83.36% | |||
| Earnings from Continuing Operations | 485.48% | -86.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 485.48% | -86.65% | |||
| EBIT | -26.08% | -11.68% | |||
| EBITDA | -19.02% | -8.01% | |||
| EPS Basic | 484.96% | -86.65% | |||
| Normalized Basic EPS | -33.37% | -12.68% | |||
| EPS Diluted | 500.56% | -86.96% | |||
| Normalized Diluted EPS | -33.30% | -12.65% | |||
| Average Basic Shares Outstanding | 0.04% | 0.02% | |||
| Average Diluted Shares Outstanding | -0.06% | -0.01% | |||
| Dividend Per Share | -100.00% | 0.00% | |||
| Payout Ratio | -0.83% | 6.50% | |||